Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,867.50
-4.2683-0.23%
Number of Gainers:5
Number of Losers:14
Number of Flat:- -
PE:- -
High:1,871.60
Open:1,870.34
Low:1,853.56
Close:1,871.77
Volume:134.66M
Turnover:8.34B
Market Cap:1.52T
Float Cap:1.48T

Loading ...

Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run

Simply Wall St.
·
Yesterday

Pfizer Pivots: New Trials Target Obesity, Cancer, Autoimmune

TIPRANKS
·
Aug 29

BioNTech SE Slides as Bold HIV Bet Takes Shape

TIPRANKS
·
Aug 29

Abbott, Vistra, Unity, United, Nu: Insider Shockwave

TIPRANKS
·
Aug 29

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Dow Jones
·
Aug 29

Novavax Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 29

US Stocks Weekly: AI Refuel

Reuters
·
Aug 29

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Biontech SE Stock (BNTX) Closed Down by 8.37% on Aug 28: What Signal Does It Send?

TradingKey
·
Aug 29

Does Peer-Reviewed Phase 1 Soquelitinib Data Reshape The Bull Case For Corvus Pharmaceuticals (CRVS)?

Simply Wall St.
·
Aug 29

BioNTech Stock Falls on Cancer Vaccine Setback Days After Moderna's Big Win

Dow Jones
·
Aug 29

Pfizer EVP Cecile Guegan Files Initial Beneficial Ownership Statement

Reuters
·
Aug 29

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 29

BioNTech on Track for Worst Day Since March After Ending Colorectal Cancer Trial

Reuters
·
Aug 29

Pfizer Extends Tucatinib Access With New Continuation Study: What Investors Should Know

TIPRANKS
·
Aug 29

Pfizer Expands Autoimmune Pipeline With New Early-Stage Trial of PF-08154225

TIPRANKS
·
Aug 29

Pfizer Targets China’s Obesity Market With New Phase 3 Berobenatide Trial

TIPRANKS
·
Aug 29

BioNTech Stock (BNTX) Is Tumbling on Friday – Here’s Why

TIPRANKS
·
Aug 29

Cevumeran trial termination a ‘clear setback’ for BioNTech, says BMO Capital

TIPRANKS
·
Aug 29

U.S. Stocks on the MOVE-Halliburton, BioNTech, Kazia Therapeutics

Reuters
·
Aug 29